JP2004506086A5 - - Google Patents

Download PDF

Info

Publication number
JP2004506086A5
JP2004506086A5 JP2002521535A JP2002521535A JP2004506086A5 JP 2004506086 A5 JP2004506086 A5 JP 2004506086A5 JP 2002521535 A JP2002521535 A JP 2002521535A JP 2002521535 A JP2002521535 A JP 2002521535A JP 2004506086 A5 JP2004506086 A5 JP 2004506086A5
Authority
JP
Japan
Prior art keywords
lps
strain
gal
glc
mutant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002521535A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004506086A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2001/001225 external-priority patent/WO2002016440A2/en
Publication of JP2004506086A publication Critical patent/JP2004506086A/ja
Publication of JP2004506086A5 publication Critical patent/JP2004506086A5/ja
Pending legal-status Critical Current

Links

Images

JP2002521535A 2000-08-25 2001-08-27 インフルエンザ菌感染症の予防用ワクチンとしてのインフルエンザ菌リポ多糖内部コアオリゴ糖エピトープ Pending JP2004506086A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22785000P 2000-08-25 2000-08-25
PCT/CA2001/001225 WO2002016440A2 (en) 2000-08-25 2001-08-27 Haemophilus influenzae lipopolysaccharide inner-core oligosaccharide epitopes as vaccines for the prevention of haemophilus influenzae infections

Publications (2)

Publication Number Publication Date
JP2004506086A JP2004506086A (ja) 2004-02-26
JP2004506086A5 true JP2004506086A5 (enExample) 2008-10-16

Family

ID=22854724

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002521535A Pending JP2004506086A (ja) 2000-08-25 2001-08-27 インフルエンザ菌感染症の予防用ワクチンとしてのインフルエンザ菌リポ多糖内部コアオリゴ糖エピトープ

Country Status (9)

Country Link
US (1) US7364739B2 (enExample)
EP (1) EP1313771B1 (enExample)
JP (1) JP2004506086A (enExample)
AT (1) ATE357461T1 (enExample)
AU (1) AU2001285633A1 (enExample)
CA (1) CA2420477A1 (enExample)
DE (1) DE60127421T8 (enExample)
ES (1) ES2284681T3 (enExample)
WO (1) WO2002016440A2 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7527797B1 (en) 2000-09-01 2009-05-05 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Vibrio cholerae 0139 conjugate vaccines
HUP0700044A2 (en) 2004-05-14 2009-03-30 Ca Nat Research Council Conserved inner core lipopolysaccharide epitopes as multi-species vaccine candidates
US8795680B2 (en) * 2006-07-21 2014-08-05 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods for conjugation of oligosaccharides or polysaccharides to protein carriers through oxime linkages via 3-deoxy-D-manno-octulsonic acid
JP2008125425A (ja) * 2006-11-20 2008-06-05 Osaka Univ 核酸の増幅反応に用いる繰返し配列結合プライマー及びその利用
CA2680038A1 (en) * 2007-03-08 2008-09-12 The Governors Of The University Of Alberta Bacterial endotoxin for the prevention of metabolic disorders and bacterial infections
WO2016007891A1 (en) * 2014-07-10 2016-01-14 University Of Iowa Research Foundation Vaccine for nontypeable haemophilus influenzae

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0347425B1 (en) 1987-03-02 1995-12-27 Whitehead Institute For Biomedical Research Recombinant mycobacterial vaccine
US5504005A (en) 1987-03-02 1996-04-02 Albert Einstein College Of Medicine Of Yeshiva University Recombinant mycobacterial vaccine
US5204098A (en) * 1988-02-16 1993-04-20 The United States Of America As Represented By The Department Of Health And Human Services Polysaccharide-protein conjugates
ZA894589B (en) * 1989-02-09 1991-02-27 K Sudan Krishan Semi-flexible or flexible phenolic foam
CA2076753A1 (en) 1990-02-26 1991-08-27 Anthony J. Radford Shuttle plasmid for escherichia coli and mycobacteria
GB9015888D0 (en) 1990-07-19 1990-09-05 Smithkline Biolog Vectors
US5153312A (en) * 1990-09-28 1992-10-06 American Cyanamid Company Oligosaccharide conjugate vaccines
WO1992011361A1 (en) 1990-12-18 1992-07-09 The General Hospital Corporation Improved vaccines
EP0587775A4 (en) 1991-06-06 1994-11-02 Medimmune Inc INDUCTION OF THE CTL RESPONSE BY FOREIGN ANTIGENS EXPRESSED IN MYCOBACTERIES.
US5283185A (en) * 1991-08-28 1994-02-01 University Of Tennessee Research Corporation Method for delivering nucleic acids into cells
WO1994016737A1 (en) 1993-01-26 1994-08-04 Weiner David B Compositions and methods for delivery of genetic material
GB9326174D0 (en) 1993-12-22 1994-02-23 Biocine Sclavo Mucosal adjuvant
US20030072774A1 (en) 1994-06-10 2003-04-17 Diane M. Gajewczyk Proteinaceous adjuvants
US6019982A (en) 1994-08-26 2000-02-01 The Administrators Of The Tulane Educational Fund Mutant enterotoxin effective as a non-toxic oral adjuvant
US5527928A (en) * 1994-09-30 1996-06-18 Nantz; Michael H. Cationic transport reagents
US6207157B1 (en) * 1996-04-23 2001-03-27 The United States Of America As Represented By The Department Of Health And Human Services Conjugate vaccine for nontypeable Haemophilus influenzae
CA2264970A1 (en) 1998-03-10 1999-09-10 American Cyanamid Company Antigenic conjugates of conserved lipolysaccharides of gram negative bacteria
US6248329B1 (en) * 1998-06-01 2001-06-19 Ramaswamy Chandrashekar Parasitic helminth cuticlin nucleic acid molecules and uses thereof
DE19844191A1 (de) 1998-09-28 2000-03-30 Pharma Zentrale Gmbh Lipopolysaccharide aus Escherichia coli
DE69926261T2 (de) * 1998-12-15 2006-05-24 Exiqon A/S Koppeln an feste phasen von kohlenhydraten, die von lipopolysacchariden abgeleitet sind
CA2374235A1 (en) 1999-05-18 2000-11-23 University Of Iowa Research Foundation Production of complex carbohydrates

Similar Documents

Publication Publication Date Title
Kogan et al. Structural and immunochemical characterization of the type VIII group B Streptococcus capsular polysaccharide
Wakarchuk et al. Functional relationships of the genetic locus encoding the glycosyltransferase enzymes involved in expression of the lacto-N-neotetraose terminal lipopolysaccharide structure in Neisseria meningitidis
EP2142660B1 (en) Methods and systems for o-glycosylating proteins
EP1870468A2 (en) LPS with reduced toxicity from genetically modified gram negative bacteria
Wakarchuk et al. Structure of an α‐2, 6‐sialylated lipooligosaccharide from Neisseria meningitidis immunotype L1
Hood et al. Genetic basis for expression of the major globotetraose-containing lipopolysaccharide from H. influenzae strain Rd (RM118)
Månsson et al. A new structural type for Haemophilus influenzae lipopolysaccharide: structural analysis of the lipopolysaccharide from nontypeable Haemophilus influenzae strain 486
Kogan et al. Structural elucidation of the novel type VII group B Streptococcus capsular polysaccharide by high resolution NMR spectroscopy
Cox et al. Structural analysis of the lipopolysaccharide from Neisseria meningitidis strain BZ157 galE: localisation of two phosphoethanolamine residues in the inner core oligosaccharide
AU779322B2 (en) Production of complex carbohydrates
Guo et al. Recent progress on the chemical synthesis of bacterial non-2-ulosonic acids
US7537766B2 (en) Neisseria meningitidis inner core lipo-oligosaccharide epitopes, multivalent conjugates thereof and immunogenic compositions thereof
US7364739B2 (en) Haemophilus influenzae lipopolysaccharide inner-core oligosaccharide epitopes as vaccines for the prevention of Haemophilus influenzae infections
Yildirim et al. An alternate pattern for globoside oligosaccharide expression in Haemophilus influenzae lipopolysaccharide: structural diversity in nontypeable strain 1124
CN101014698A (zh) 作为多种疫苗候选物的保守性内核脂多糖表位
EP1747262B1 (en) Conserved inner core lipopolysaccharide epitopes as multi-species vaccine candidates
AU2020293566B2 (en) Rhamnose-polysaccharides
US8975043B2 (en) Enzymatic degradation of lipid A fatty acids of bacterial LPS
Sella Chemical synthesis of oligosaccharide antigens as vaccine candidates for Streptococcus suis serotypes 2 and 14
Miller Modified carbohydrate cancer vaccines for breaking immune self-tolerance
Lundström Detailed structural studies towards the understanding of lipopolysaccharide glycan expression in non-typeable Haemophilus influenzae
KR20070031936A (ko) 다종 백신 후보로서의 보존된 내부 코어 지질다당류에피토프